Tower Research Capital (TRC)’s Pulmonx LUNG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.7K | Buy |
11,402
+6,718
| +143% | +$11.1K | ﹤0.01% | 3690 |
|
|
2025
Q4 | $10.4K | Sell |
4,684
-10,639
| -69% | -$20K | ﹤0.01% | 3791 |
|
|
2025
Q3 | $24.8K | Buy |
15,323
+9,054
| +144% | +$18.9K | ﹤0.01% | 3105 |
|
|
2025
Q2 | $16.2K | Buy |
6,269
+1,889
| +43% | +$7.45K | ﹤0.01% | 3790 |
|
|
2025
Q1 | $29.5K | Sell |
4,380
-2,053
| -32% | -$14.5K | ﹤0.01% | 2626 |
|
|
2024
Q4 | $43.7K | Buy |
6,433
+572
| +10% | +$3.77K | ﹤0.01% | 2638 |
|
|
2024
Q3 | $48.6K | Sell |
5,861
-1,691
| -22% | -$12.2K | ﹤0.01% | 2735 |
|
|
2024
Q2 | $47.9K | Buy |
7,552
+6,884
| +1,031% | +$52.9K | ﹤0.01% | 3135 |
|
|
2024
Q1 | $6.19K | Sell |
668
-10,242
| -94% | -$120K | ﹤0.01% | 4413 |
|
|
2023
Q4 | $139K | Sell |
10,910
-846
| -7% | -$8.81K | ﹤0.01% | 2377 |
|
|
2023
Q3 | $121K | Buy |
11,756
+10,770
| +1,092% | +$125K | ﹤0.01% | 1839 |
|
|
2023
Q2 | $12.9K | Sell |
986
-81
| -8% | -$991 | ﹤0.01% | 3820 |
|
|
2023
Q1 | $12K | Sell |
1,067
-19,140
| -95% | -$189K | ﹤0.01% | 4094 |
|
|
2022
Q4 | $170K | Buy |
20,207
+17,929
| +787% | +$171K | 0.01% | 1420 |
|
|
2022
Q3 | $38K | Sell |
2,278
-2,974
| -57% | -$54.8K | ﹤0.01% | 3403 |
|
|
2022
Q2 | $77K | Sell |
5,252
-4,639
| -47% | -$95.6K | ﹤0.01% | 2498 |
|
|
2022
Q1 | $245K | Buy |
9,891
+7,675
| +346% | +$198K | ﹤0.01% | 1586 |
|
|
2021
Q4 | $71K | Buy |
2,216
+1,295
| +141% | +$47.3K | ﹤0.01% | 2482 |
|
|
2021
Q3 | $34K | Sell |
921
-4,154
| -82% | -$163K | ﹤0.01% | 3264 |
|
|
2021
Q2 | $224K | Buy |
5,075
+2,840
| +127% | +$124K | 0.01% | 1838 |
|
|
2021
Q1 | $102K | Buy |
2,235
+1,994
| +827% | +$114K | ﹤0.01% | 2567 |
|
|
2020
Q4 | $17K | Buy |
+241
| New | +$11.8K | ﹤0.01% | 3968 |
|
Other funds holding LUNG
SCM
ECM
VCM
